Clinical Trials Search Results - University of Colorado Hospital

Skip to Content

Clinical Trials Search Results

Search for

in

In Progress (7)

Showing 1-7 of 7

Sorted By:

A-Z
Z-A

A Phase 2 Study of PF-04449913 for the Treatment of Acute Leukemia Patients with High Risk of Post-Allogeneic Stem Cell Transplantation Relapse
A Phase 2, Multi-Center, Open-label, Randomized, Parallel-Group Study of A Lenalidomide (Revlimid«) Regimen or A Sequential Azacitidine (Vidaza«) plus Lenalidomide (Revlimid«) Regimen Versus Azacitidine (Vidaza«) Regimen for Therapy of Older Subjects with Newly Diagnosed Acute Myeloid Leukemia
Celgene RV-AML-PI - 0759: Sequential Treatment with Azacitidine and Lenalidomide for Relapsed and Refractory Patients with Acute Myeloid Leukemia
Exploiting Synergy in Chronic Myelogenous Leukemia: A Phase Ib Evaluation of Dasatinib plus Cyclosporine in patients with Ph+ leukemia refractory to or intolerant of imatinib mesylate (ESCAPE1b Trial)
Multi-center, open-label randomized study of single or double myeloablative cord blood transplantation with or without infusion of off-the-shelf ex vivo expanded cryopreserved cord blood progenitor cells in patients with hematologic malignancies
Pfizer B1931022: An Open-label, Randomized Phase 3 Study of Inotuzumab Ozogamicin Compared to a Defined Investigator's Choice in Adult Patients with Relapsed or Refractory CD22 Positive Acute Lymphoblastic Leukemia (ALL)
SWOG S1117: A Randomized Phase II Study of Azacitidine in Combination with Lenalidomide (NSC-7036813) versus Azacitidine Alone versus Azacitidine in Combination with Vorinostat (NSC - 701852) for Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)

Showing trials 1-7 of 7